Publish date:

Elanco Animal Health, 3D Systems: 5 Stock Gainers for Wednesday

Elanco Animal Health, Ocular Therapeutix, 3D Systems, Perion Networks and Quanterix are five of Wednesday's top stock gainers.

Stocks ended sharply higher Wednesday after President Donald Trump said he would consider alternative aid measures a day after halting coronavirus stimulus talks until after the presidential election.

Here are some of the top stock gainers for Wednesday.

1. Elanco Animal Health | Percentage Increase 13%

Elanco Animal Health  (ELAN) - Get Elanco Animal Health, Inc. Report climbed after hedge fund Sachem Head Capital Management said it owned a $1.2 billion stake in the animal medicine company and plans to push for changes.

2. Ocular Therapeutix | Percentage Increase 28%

Ocular Therapeutix  (OCUL) - Get Ocular Therapeutix Inc Report advanced after the biopharma reported preliminary third-quarter net revenue of $5.8 million to $5.9 million, a sequential increase of more than 250%. The company is scheduled to report third-quarter results on Nov. 5.

TheStreet Recommends

3. 3D Systems | Percentage Increase 18%

3D Systems  (DDD) - Get 3D Systems Corporation Report rose due to speculation that that Tesla  (TSLA) - Get Tesla Inc Report was turning to more additive manufacturing in its vehicle production. Traders have circulated a job posting from Tesla indicating the company is looking for a full-time "Additive Manufacturing Technician" to join its team in Nevada, the Fly reported.

4. Perion Network | Percentage Increase 11%

Shares of Perion Network  (PERI) - Get Perion Network Ltd Report climbed after the digital advertising company increased its revenue and adjusted Ebitda guidance for the second half of 2020. The Israel-based company said the improved outlook is driven by a faster recovery of its advertising business. 

5. Quanterix | Percentage Increase 17%

Quanterix  (QTRX) - Get Quanterix Corporation Report advanced after the medical device company said it had entered into an $18.2 million Phase 2 contract with the National Institutes of Health to accelerate the development, scale-up and deployment of a SARS-CoV-2 antigen test based on Quanterix’ ultra-sensitive Simoa technology. SARS-CoV-2 is the virus that causes the coronavirus disease.